wet AMD

eyeball

Pharma

Ocular's ophthalmologic version of Inlyta bests Eylea in ph. 3

Ocular's hydrogel eye injection, Axpaxli, is a formulation of Pfizer's Inlyta that the company is pursuing in wet age-related macular degeneration.

Zoey Becker Feb 17, 2026 12:15pm

Graham

Roche eyes busy 2026 despite Vabysmo miss, Tecentriq flop

Jan 29, 2026 11:23am

launch button

Ocular hires Eylea launch architect to challenge Regeneron

Jan 23, 2026 10:00am

Eylea HD

Regeneron wins 2 Eylea nods, ramping up competition with Roche

Nov 20, 2025 11:53am

Ocular Therapeutix sharpens focus with retina-centric rebrand

Jun 27, 2025 10:05am

Close-up of human eye

GLP-1 use in diabetes linked to possible eye disease risk: study

Jun 6, 2025 7:25am